Rhythm Pharmaceuticals (NASDAQ:RYTM) Insider Sells $912,695.91 in Stock
One daysingle sourceOne outlet reported this, once - no second voice in this corpus.
All 1 reports on Mon, 17 August 2026
What it is about
Stifel NicolausAlastair GarfieldVanguard Group IncWells Fargo CompanyNews Ratings For Rhythm Pharmaceuticals DailyRhythm PharmaceuticalsRhythm Pharmaceuticals Stock DownPrimecap Management CoQuarter For Rhythm PharmaceuticalsCitigroupRhythm Pharmaceuticals Company ProfileRoyal BankNasdaqJupiter TopcoCanadaBlackrock, Nova Scotia, Canada
Who published it, and when
How it spread - 1 original report
Mon, 17 August 2026
1 report- themarketsdaily.com23:09first to report
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Free Report) insider Alastair Garfield sold 7,763 shares of the stock in a transaction on Thursday, August 13th. The stock was sold at an average price of $117.57, for a total value of $912,695.91. Following the completion of the transaction, the insider owned 2,295 shares of the company’s stock, […]